Biotechnology Allogene Therapeutics to Report Second Quarter 2020 Financial Results on August 5, 2020 July 28, 2020
Biotechnology Ivy Brain Tumor Center and BridgeBio Pharma’s QED Therapeutics Announce Dosing of First Patient in Investigator-Initiated Phase 0/2 Clinical Trial of Infigratinib in Recurrent Glioblastoma July 28, 2020
Biotechnology Amicus Therapeutics to Announce Second Quarter 2020 Financial Results on August 10, 2020 July 28, 2020
Biotechnology Reata Announces Initiation of Investigator-Sponsored Study Evaluating Bardoxolone for Complications Associated with COVID-19 July 28, 2020
Health Chi-Med’s NDA for Savolitinib in Non-Small Cell Lung Cancer Granted Priority Review in China July 28, 2020
Search
Health
